Latest News and Press Releases
Want to stay updated on the latest news?
-
Bile Tract Cancer expansion study opens following clearance of Imugene’s MAST trial high dose cohort
Imugene opened enrollment for its CF-33 (VAXINIA) expansion study in bile tract cancer (cholangiocarcinoma) patients.